ClinicalTrials.Veeva

Menu

Ultrasound for Detection of Prostate Cancer (SURF)

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Completed

Conditions

Prostate Cancer

Treatments

Device: SURF

Study type

Interventional

Funder types

Other

Identifiers

NCT05736094
248446
313778 (Other Grant/Funding Number)

Details and patient eligibility

About

Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.

Full description

Prospectively recruited patients before prostatectomy and/or definitive radiotherapy will be included in the study. Dual-frequency ultrasound imaging will be compared to standard transrectal ultrasound and MRI. Imaging of primary tumor with dual-frequency ultrasound technology including the use of microbubble contrast-media.

A prostate biopsy and blood sample will be taken from each patient, for histopathology and explorative biomarkers.

Enrollment

11 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years onwards
  • Signed written informed consent to perform rectal and transperineal ultrasound

Exclusion criteria

  • N/A

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

11 participants in 1 patient group

Dual-frequency ultrasound
Other group
Description:
Dual-frequency ultrasound for detection of prostate cancer
Treatment:
Device: SURF

Trial contacts and locations

1

Loading...

Central trial contact

Wolfgang Lilleby, MD PhD; Lise N Torpen, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems